Status: Not yet recruiting
Safety and Efficacy of NDTx-03 in Children and Adolescents With ASD or SCD
The purpose of this study is to evaluate the safety of NDTx-03 used together with treatment as usual (TAU) and to determine whether NDTx-03 plus TAU is more effective than TAU alone in improving social situation recognition and interaction in children and adolescents with autism spectrum disorder (ASD) or social communication disorder (SCD).
Participants needed: 156
Trial details
Age: 10-18Biological sex: AllType: InterventionalSponsor: Neudive Inc.Updated: Aug 18, 2026Locations: 6
Eligibility criteria
Children and adolescents aged 10 to 18 years. [+9]
Clinically significant behavioral problems, emotional regulation problems, psych... [+8]